China To Step Up Supervision Of APIs And Drug Excipients – PDA-FDA Supply Chain Conference
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA is planning to launch a drug master file system to establish better controls for active pharmaceutical ingredients and drug excipients